Home › Trial NCT02256800
Escalated Dose of Irinotecan in mCRC
- Trial IDNCT02256800
- StatusCompleted
- PhaseN/A
- Study typeInterventional
- SponsorJaw-Yuan Wang, MD, PhD
- Enrollment213
- Start date2014-08-13
- ConditionsMetastatic Colorectal Cancer
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.